CARDIOME PHARMA NEW CRME (NASDAQ) $ 8.11 Change: -0.18 -2.22% | Volume: 571,074

CARDIOME PHARMA - Fundamental Profile

Company Information

Ticker Symbol: CRME
Exchange: NASD
Contact Info:
CEO/President:
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), and a pre-clinical program directed at improving cardiovascular function.

Share Information

Shares Outstanding: 63,760 (000) Market Value: 528,590 ($000)
Percentage of Inst.Shareholders: 58.07% Number of Inst.Shareholders: N/A%
Last Quarter Sales: 0.20 ($Mil.) Last Quarter Net Income: -17.92 ($Mil.)
Last Quarter EPS: -0.28 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -1.50
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -19.50 18.51
MERCK CO INC -32.20 34.30
JOHNSON AND JOH +18.40 70.67
SCHERING PLOUGH -28.80 19.26
BRISTOL MYERS S -18.00 21.49